Double-blinded, placebo-controlled plasmid GHRH trial for cancer-associated anemia in dogs

Molecular Therapy

Volumn 16, Issue 5, 2008, Pages 862-870

  Bodles Brakhop, Angela M ^a   Brown, Patricia A ^b   Pope, Melissa A ^a   Draghia Akli, Ruxandra ^a  

^a VGX Pharmaceuticals Inc   (United States)

^b VGX Animal Health Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; GROWTH HORMONE RELEASING FACTOR; HEMOGLOBIN; PLACEBO; SOMATOMEDIN C; SYNTHETIC DNA;

ADENOCARCINOMA; ANEMIA; ANGIOSARCOMA; ARTICLE; CARCINOMA; CONTROLLED STUDY; DOG DISEASE; DRUG EFFICACY; DRUG RESPONSE; ELECTROPORATION; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PLASMACYTOMA; MASTOCYTOMA; NONHUMAN; PLASMID; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SARCOMA; SINGLE DRUG DOSE; SURVIVAL TIME; WEIGHT GAIN; WEIGHT REDUCTION;

CANIS FAMILIARIS;

EID: 42549129119     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.31     Document Type: Article

References (47)

1. JE Morley DR Thomas MM Wilson Cachexia: pathophysiology and clinical relevance Am J Clin Nutr 83 2006 735 743
2. GR Morrow PL Andrews JT Hickok JA Roscoe S Matteson Fatigue associated with cancer and its treatment Support Care Cancer 10 2002 389 398
3. AJ Sytkowski Does erythropoietin have a dark side? Epo signaling and cancer cells Sci STKE 2007 2007 pe38
4. SY Lai EE Childs S Xi FM Coppelli WE Gooding A Wells Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma Oncogene 24 2005 4442 4449
5. MM Ramsey RL Ingram AB Cashion AH Ng JM Cline AF Parlow Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis Endocrinology 143 2002 4139 4142
6. N Barabutis E Tsellou AV Schally S Kouloheri A Kalofoutis H Kiaris Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor Proc Natl Acad Sci USA 104 2007 5575 5579
7. PJ Jenkins A Mukherjee SM Shalet Does growth hormone cause cancer? Clin Endocrinol (Oxf) 64 2006 115 121
8. CM de Jager LJ de Heide G van den Berg A Wolthuis WD van Schelven Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment Neth J Med 65 2007 263 266
9. S Mukhina HC Mertani K Guo KO Lee PD Gluckman PE Lobie Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone Proc Natl Acad Sci USA 101 2004 15166 15171
10. AS Khan IW Anscombe KK Cummings MA Pope LC Smith R Draghia-Akli Effects of plasmid-mediated growth hormone-releasing hormone supplementation on LL-2 adenocarcinoma in mice Mol Ther 8 2003 459 466
11. AS Khan LC Smith IW Anscombe KK Cummings MA Pope R Draghia-Akli Growth hormone releasing hormone plasmid supplementation, a potential treatment for cancer cachexia, does not increase tumor growth in nude mice Cancer Gene Ther 12 2005 54 60
12. PA Brown WC Davis R Draghia-Akli Immune-enhancing effects of growth hormone-releasing hormone delivered by plasmid injection and electroporation Mol Ther 10 2004 644 651
13. R Draghia-Akli KA Hahn GK King K Cummings RH Carpenter Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer Mol Ther 6 2002 830 836
14. CM Tone DM Cardoza RH Carpenter R Draghia-Akli Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs Cancer Gene Ther 11 2004 389 396
15. R Draghia-Akli KK Cummings AS Khan PA Brown RH Carpenter Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs J Anim Sci 81 2003 2301 2310
16. G Aimaretti G Corneli P Razzore S Bellone C Baffoni J Bellone Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults J Endocrinol Invest 21 1998 506 511
17. JE Eigenmann DF Patterson J Zapf ER Froesch Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation Acta Endocrinol (Copenh) 105 1984 294 301
18. M Bossola F Pacelli GB Doglietto Novel treatments for cancer cachexia Expert Opin Investig Drugs 16 2007 1241 1253
19. R Heller M Jaroszeski A Atkin D Moradpour R Gilbert J Wands In vivo gene electroinjection and expression in rat liver FEBS Lett 389 1996 225 228
20. T Nishi K Yoshizato S Yamashiro H Takeshima K Sato K Hamada High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation Cancer Res 56 1996 1050 1055
21. C Favard DS Dean MP Rols Electrotransfer as a non viral method of gene delivery Curr Gene Ther 7 2007 67 77
22. C Trollet C Bloquel D Scherman P Bigey Electrotransfer into skeletal muscle for protein expression Curr Gene Ther 6 2006 561 578
23. Y Isaka E Imai Electroporation-mediated gene therapy Expert Opin Drug Deliv 4 2007 561 571
24. J Gehl T Skovsgaard LM Mir Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs Anticancer Drugs 9 1998 319 325
25. GJ Prud'homme Y Glinka AS Khan R Draghia-Akli Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases Curr Gene Ther 6 2006 243 273
26. R Giardino M Fini V Bonazzi R Cadossi A Nicolini A Carpi Electrochemotherapy a novel approach to the treatment of metastatic nodules on the skin and subcutaneous tissues Biomed Pharmacother 60 2006 458 462
27. A Gothelf LM Mir J Gehl Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation Cancer Treat Rev 29 2003 371 387
28. A Colao P Marzullo S Spiezia D Ferone A Giaccio G Cerbone Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects J Clin Endocrinol Metab 84 1999 1986 1991
29. DP Kotler Cachexia Ann Intern Med 133 2000 622 634
30. EE Müller V Locatelli D Cocchi Neuroendocrine control of growth hormone secretion Physiol Rev 79 1999 511 607
31. KC Leung C Howe LY Gui G Trout JD Veldhuis KK Ho Physiological and pharmacological regulation of 20-kDa growth hormone Am J Physiol Endocrinol Metab 283 2002 E836 E843
32. R Draghia-Akli ML Fiorotto LA Hill PB Malone DR Deaver RJ Schwartz Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs Nat Biotechnol 17 1999 1179 1183
33. M Dennler EM Lange O Schmied B Kaser-Hotz Imaging diagnosis—metastatic hemangiosarcoma causing cerebral hemorrhage in a dog Vet Radiol Ultrasound 48 2007 138 140
34. D Behl A Jatoi Pharmacological options for advanced cancer patients with loss of appetite and weight Expert Opin Pharmacother 8 2007 1085 1090
35. RA Femia RE Goyette The science of megestrol acetate delivery: potential to improve outcomes in cachexia BioDrugs 19 2005 179 187
36. DH Jho SM Cole EM Lee NJ Espat Role of omega-3 fatty acid supplementation in inflammation and malignancy Integr Cancer Ther 3 2004 98 111
37. A Folador SM Hirabara SJ Bonatto J Aikawa RK Yamazaki R Curi Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats Int J Cancer 120 2007 344 350
38. CA Hauser MR Stockler MH Tattersall Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review Support Care Cancer 14 2006 999 1011
39. JL Ryan JK Carroll EP Ryan KM Mustian K Fiscella GR Morrow Mechanisms of cancer-related fatigue Oncologist 12 Suppl. 1 2007 22 34
40. N Abdelrazik M Fouda Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study Hematology 12 2007 533 541
41. N Voravud V Sriuranpong H Suwanrusme Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy J Med Assoc Thai 90 2007 1082 1088
42. MV Vitiello KE Moe GR Merriam G Mazzoni DH Buchner RS Schwartz Growth hormone releasing hormone improves the cognition of healthy older adults Neurobiol Aging 27 2006 318 323
43. SL Teichman A Neale B Lawrence C Gagnon JP Castaigne LA Frohman Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults J Clin Endocrinol Metab 91 2006 799 805
44. JD Veldhuis JM Patrie K Frick JY Weltman AL Weltman Administration of recombinant human GHRH-1,44-amide for 3 months reduces abdominal visceral fat mass and increases physical performance measures in postmenopausal women Eur J Endocrinol 153 2005 669 677
45. X Li EM Eastman RJ Schwartz R Draghia-Akli Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences Nat Biotechnol 17 1999 241 245
46. R Draghia-Akli X Li RJ Schwartz Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector Nat Biotechnol 15 1997 1285 1289
47. H Hebel H Attra A Khan R Draghia-Akli Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device Vaccine 24 2006 4607 4614